سعر ايتوسيد 100 مجم /5 مل فيال 2025

Etoposide 100 mg/5 ml (20 mg/ml) concentrate for solution for IV infusion, 1 vial (Etosid; Cipla, India; distributed by Star International Company).

• Refractory testicular tumors, in combination with other approved chemotherapeutic agents, in patients who have already received appropriate surgery, chemotherapy and radiotherapy.Population: AdultsDailyMed (U.S. National Library of Medicine)
• First-line treatment of small cell lung cancer in combination with other approved chemotherapeutic agents.Population: AdultsDailyMed (U.S. National Library of Medicine)

• Dose-limiting myelosuppression (granulocyte nadir day 7-14, platelet nadir day 9-16); nausea and vomiting; alopecia; transient hypotension after rapid IV administration.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Previous hypersensitivity to etoposide or any component of the formulation.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: administer under the supervision of a physician experienced in cancer chemotherapy; severe myelosuppression with resulting infection or bleeding may occur.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Etoposide can cause fetal harm (teratogenic in mice and rats); women of childbearing potential should avoid becoming pregnant.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Unknown whether excreted in human milk; because of potential serious adverse reactions in nursing infants, decide whether to discontinue nursing or the drug.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Etoposide: Semisynthetic podophyllotoxin derivative; inhibits topoisomerase II causing DNA strand breaks and arrest in late S/G2 phase (US etoposide labeling).